Deutscher Krebskrongress 2024 in Berlin

The German Cancer Congress (DKK) 2024 is dedicated to the profound changes in cancer medicine over the last 20 years. With groundbreaking advances in diagnostics and therapy, such as molecular therapies, immunotherapies, cellular therapies and personalised tumour vaccinations, the congress is all about innovation. A central focus is on the need for multidisciplinary expertise and collaboration in networks in order to manage the variety of therapeutic options and biomarker tests.

Another focus of DKK 2024 is the joint therapy decision with patients. This includes care, the selection of intensified therapies and research priorities. The congress raises questions about health literacy among patients and oncological teams, the role of diagnostic disciplines and access to knowledge and new therapy options for all oncological stakeholders. The DKK 2024 offers a platform to discuss these challenges in an interdisciplinary, intersectoral and intergenerational manner.

The DKK 2024 relies on the active involvement of participants, both on site in symposia on therapy, diagnostics, care or health policy and in advance by submitting abstracts. Special attention will be paid to the study and research data of young oncologists. The congress will highlight topics such as holistic care, interactions between treatment partners, health literacy, artificial intelligence in diagnostics and therapy, prevention, tumour boards and a special programme for young oncologists and students.

The text is based on a language draft by ChatGPT. The author has thoroughly reviewed and revised the content before publication.